The microRNA-29 family in cartilage homeostasis and osteoarthritis

Journal of Molecular Medicine

Volumn 94, Issue 5, 2016, Pages 583-596

  Le, Linh T T ^a   Swingler, Tracey E ^a   Crowe, Natalie ^a   Vincent, Tonia L ^b   Barter, Matthew J ^c   Donell, Simon T ^d   Delany, Anne M ^e   Dalmay, Tamas ^a   Young, David A ^c   Clark, Ian M ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^e UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Chondrocyte; MicroRNA; Osteoarthritis; Sry related box 9; Wnt pathway

Indexed keywords

CK2A2 PROTEIN; DVL3 PROTEIN; FRAT2 PROTEIN; FZD3 PROTEIN; FZD5 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; MICRORNA 144 3P; MICRORNA 21 5P; MICRORNA 29; MICRORNA 29A; MICRORNA 29A 3P; MICRORNA 29B; MICRORNA 29B 3P; MICRORNA 29C; MICRORNA 29C 3P; MICRORNA 370 5P; SMAD PROTEIN; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; MICRORNA; MIRN29 MICRORNA, HUMAN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE INJURY; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; FEMALE; GENE EXPRESSION; HIP REPLACEMENT; HOMEOSTASIS; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; KNEE MENISCUS; MALE; MONOLAYER CULTURE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PROMOTER REGION; TRANSCRIPTION INITIATION SITE; TRANSIENT TRANSFECTION; WNT SIGNALING PATHWAY; ANIMAL; CHONDROCYTE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MULTIGENE FAMILY; PATHOLOGY; SIGNAL TRANSDUCTION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; CARTILAGE, ARTICULAR; CHONDROCYTES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; MALE; MICE; MICRORNAS; MIDDLE AGED; MULTIGENE FAMILY; OSTEOARTHRITIS; SIGNAL TRANSDUCTION; SOX9 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84950247490     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-015-1374-z     Document Type: Article

References (58)

1. Zhuo Y, Gao G, Shi JA, Zhou X, Wang X (2013) miRNAs: biogenesis, origin and evolution, functions on virus-host interaction. Cell Physiol Biochem Int J Exp Cell Physiol Biochem 32:499–510
2. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233
3. Kozomara A, Griffiths-Jones S (2014) miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42:D68–D73
4. Thysen S, Luyten FP, Lories RJ (2015) Targets, models and challenges in osteoarthritis research. Dis Model Mech 8:17–30
5. Hunter DJ, Schofield D, Callander E (2014) The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol 10:437–441
6. Wienholds E, Koudijs M, van Eeden F, Cuppen E, Plasterk R (2003) The microRNA-producing enzyme Dicer1 is essential for zebrafish development. Nat Genet 35:217–218
7. Tuddenham L, Wheeler G, Ntounia-Fousara S, Waters J, Hajihosseini M, Clark I, Dalmay T (2006) The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett 580:4214–4217
8. Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, Yokoyama S, Kato Y, Takemoto F, Nakasa T, Yamashita S et al (2010) MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 24:1173–1185
9. Nakamura Y, Inloes JB, Katagiri T, Kobayashi T (2011) Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling. Mol Cell Biol 31:3019–3028
10. Le LT, Swingler TE, Clark IM (2013) Review: the role of microRNAs in osteoarthritis and chondrogenesis. Arthritis Rheum 65:1963–1974
11. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16:2813–2828
12. Cucchiarini M, Thurn T, Weimer A, Kohn D, Terwilliger EF, Madry H (2007) Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9. Arthritis Rheum 56:158–167
13. Nakamura Y, He X, Kato H, Wakitani S, Kobayashi T, Watanabe S, Iida A, Tahara H, Warman ML, Watanapokasin R et al (2012) Sox9 is upstream of microRNA-140 in cartilage. Appl Biochem Biotechnol 166:64–71
14. Swingler TE, Wheeler G, Carmont V, Elliott HR, Barter MJ, Abu-Elmagd M, Donell ST, Boot-Handford RP, Hajihosseini MK, Munsterberg A et al (2012) The expression and function of microRNAs in chondrogenesis and osteoarthritis. Arthritis Rheum 64:1909–1919
15. Barter MJ, Tselepi M, Gomez R, Woods S, Hui W, Smith GR, Shanley DP, Clark IM, Young DA (2015) Genome-wide microRNA and gene analysis of mesenchymal stem cell chondrogenesis identifies an essential role and multiple targets for miR-140-5p. Stem Cells. doi:10.1002/stem.2093
16. Dudek KA, Lafont JE, Martinez-Sanchez A, Murphy CL (2010) Type II collagen expression is regulated by tissue-specific miR-675 in human articular chondrocytes. J Biol Chem 285:24381–24387
17. Martinez-Sanchez A, Dudek KA, Murphy CL (2012) Regulation of human chondrocyte function through direct inhibition of cartilage master regulator SOX9 by microRNA-145 (miRNA-145). J Biol Chem 287:916–924
18. He Y, Huang C, Lin X, Li J (2013) MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases. Biochimie 95:1355–1359
19. Glasson SS, Askew R, Sheppard B, Carito B, Blanchet T, Ma H-L, Flannery CR, Peluso D, Kanki K, Yang Z et al (2005) Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434:644
20. Chia SL, Sawaji Y, Burleigh A, McLean C, Inglis J, Saklatvala J, Vincent T (2009) Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum 60:2019–2027
21. Culley KL, Hui W, Barter MJ, Davidson RK, Swingler TE, Destrument AP, Scott JL, Donell ST, Fenwick S, Rowan AD et al (2013) Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation. Arthritis Rheum 65:1822–1830
22. Himly M, Foster dN, Bottoli I, Iacovoni JS, Vogt PK (1998) The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Virology 248:295–304
23. Chong KW, Chanalaris A, Burleigh A, Jin H, Watt FE, Saklatvala J, Vincent TL (2013) Fibroblast growth factor 2 drives changes in gene expression following injury to murine cartilage in vitro and in vivo. Arthritis Rheum 65:2346–2355
24. Pais H, Nicolas FE, Soond SM, Swingler TE, Clark IM, Chantry A, Moulton V, Dalmay T (2010) Analyzing mRNA expression identifies Smad3 as a microRNA-140 target regulated only at protein level. RNA 16:489–494
25. Davidson RK, Jupp O, de Ferrars R, Kay CD, Culley KL, Norton R, Driscoll C, Vincent TL, Donell ST, Bao Y et al (2013) Sulforaphane represses matrix-degrading proteases and protects cartilage from destruction in vitro and in vivo. Arthritis Rheum 65:3130–3140
26. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC−/− colon carcinoma. Science 275:1784–1787
27. Kapinas K, Kessler C, Ricks T, Gronowicz G, Delany AM (2010) miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem 285:25221–25231
28. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B (1997) SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17:2336–2346
29. Kriegel AJ, Liu Y, Fang Y, Ding X, Liang M (2012) The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol Genomics 44:237–244
30. Riordan EA, Little C, Hunter D (2014) Pathogenesis of post-traumatic OA with a view to intervention. Best Pract Res Clin Rheumatol 28:17–30
31. Goldring MB (2012) Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther Adv Musculoskelet Dis 4:269–285
32. Crowe N, Swingler TE, Le L, Barter MJ, Wheeler G, Pais H, Donell ST, Young DA, Dalmay T, Clark IM (2015) Detecting new microRNAs in human osteoarthritic chondrocytes identifies miR-3085 as a human, chondrocyte-selective, microRNA. Osteoarthritis Cartilage. doi:10.1016/j.joca.2015.10.002
33. Kozhemyakina E, Lassar AB, Zelzer E (2015) A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation. Development 142:817–831
34. Blasioli DJ, Kaplan DL (2014) The roles of catabolic factors in the development of osteoarthritis. Tissue Eng B Rev 20:355–363
35. Staines KA, Macrae VE, Farquharson C (2012) Cartilage development and degeneration: a Wnt situation. Cell Biochem Funct 30:633–642
36. Nicolas FE, Pais H, Schwach F, Lindow M, Kauppinen S, Moulton V, Dalmay T (2008) Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140. RNA 14:2513–2520
37. Guerit D, Brondello JM, Chuchana P, Philipot D, Toupet K, Bony C, Jorgensen C, Noel D (2014) FOXO3A regulation by miRNA-29a Controls chondrogenic differentiation of mesenchymal stem cells and cartilage formation. Stem Cells Dev 23:1195–1205
38. Jin L, Zhao J, Jing W, Yan S, Wang X, Xiao C, Ma B (2014) Role of miR-146a in human chondrocyte apoptosis in response to mechanical pressure injury in vitro. Int J Mol Med 34:451–463
39. Yang M, Zhang L, Gibson GJ (2015) Chondrocyte miRNAs 221 and 483-5p respond to loss of matrix interaction by modulating proliferation and matrix synthesis. Connect Tissue Res 56:236–243
40. Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M, Fatica A, Negrini M, Peschle C, Valtieri M (2008) Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol 36:1035–1046
41. Yan C, Wang Y, Shen XY, Yang G, Jian J, Wang HS, Chen GQ, Wu Q (2011) MicroRNA regulation associated chondrogenesis of mouse MSCs grown on polyhydroxyalkanoates. Biomaterials 32:6435–6444
42. Shi S, Wang C, Acton AJ, Eckert GJ, Trippel SB (2015) Role of sox9 in growth factor regulation of articular chondrocytes. J Cell Biochem 116:1391–1400
43. Olex AL, Turkett WH, Fetrow JS, Loeser RF (2014) Integration of gene expression data with network-based analysis to identify signaling and metabolic pathways regulated during the development of osteoarthritis. Gene 542:38–45
44. van den Bosch MH, Blom AB, van Lent PL, van Beuningen HM, Blaney Davidson EN, van der Kraan PM, van den Berg WB (2014) Canonical Wnt signaling skews TGF-beta signaling in chondrocytes towards signaling via ALK1 and Smad 1/5/8. Cell Signal 26:951–958
45. Yuan XL, Meng HY, Wang YC, Peng J, Guo QY, Wang AY, Lu SB (2014) Bone-cartilage interface crosstalk in osteoarthritis: potential pathways and future therapeutic strategies. Osteoarthritis Cartilage 22:1077–1089
46. Goldring MB, Berenbaum F (2015) Emerging targets in osteoarthritis therapy. Curr Opin Pharmacol 22:51–63
47. Qin W, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM, Sung JJ, Lan HY (2011) TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol JASN 22:1462–1474
48. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A (2010) Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 39:373–384
49. Ha M, Kim VN (2014) Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15:509–524
50. Liu-Bryan R, Terkeltaub R (2015) Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol 11:35–44
51. Zhang Q, Hui W, Litherland GJ, Barter MJ, Davidson R, Darrah C, Donell ST, Clark IM, Cawston TE, Robinson JH et al (2008) Differential Toll-like receptor-dependent collagenase expression in chondrocytes. Ann Rheum Dis 67:1633–1641
52. Liu S, Wu LC, Pang J, Santhanam R, Schwind S, Wu YZ, Hickey CJ, Yu J, Becker H, Maharry K et al (2010) Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell 17:333–347
53. Mott JL, Kurita S, Cazanave SC, Bronk SF, Werneburg NW, Fernandez-Zapico ME (2010) Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J Cell Biochem 110:1155–1164
54. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS et al (2008) NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14:369–381
55. Tan M, Wu J, Cai Y (2013) Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer. Biochem Biophys Res Commun 438:673–679
56. Kapinas K, Kessler CB, Delany AM (2009) miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J Cell Biochem 108:216–224
57. Kim W, Kim M, Jho EH (2013) Wnt/beta-catenin signalling: from plasma membrane to nucleus. Biochem J 450:9–21
58. Ma B, Landman EB, Miclea RL, Wit JM, Robanus-Maandag EC, Post JN, Karperien M (2013) WNT signaling and cartilage: of mice and men. Calcif Tissue Int 92:399–411